Investigational Drug Information for Icosabutate
✉ Email this page to a colleague
What is the development status for investigational drug Icosabutate?
Icosabutate is an investigational drug.
There have been 5 clinical trials for Icosabutate.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 17th 2019.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Dyslipidemias. The leading clinical trial sponsors are Pronova BioPharma, NorthSea Therapeutics B.V., and [disabled in preview].
There are five US patents protecting this investigational drug and one hundred and five international patents.
Summary for Icosabutate
| US Patents | 5 |
| International Patents | 105 |
| US Patent Applications | 50 |
| WIPO Patent Applications | 31 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 1 (2019-07-17) |
| Vendors | 15 |
Recent Clinical Trials for Icosabutate
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 2b Study of Icosabutate in Fatty Liver Disease | NorthSea Therapeutics B.V. | Phase 2 |
| A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval | NorthSea Therapeutics B.V. | Phase 1 |
| Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects | Pronova BioPharma | Phase 1 |
Clinical Trial Summary for Icosabutate
Top disease conditions for Icosabutate
Top clinical trial sponsors for Icosabutate
US Patents for Icosabutate
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Icosabutate | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
| Icosabutate | ⤷ Try a Trial | Substituted fatty acids for treating non-alcoholic steatohepatitis | BASF AS (Oslo, NO) | ⤷ Try a Trial |
| Icosabutate | ⤷ Try a Trial | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | Pronova Biopharma Norge AS (Baerum, NO) | ⤷ Try a Trial |
| Icosabutate | ⤷ Try a Trial | Methods of preparing fatty acid derivatives | Pronova Biopharma Norge AS (Lysaker, NO) | ⤷ Try a Trial |
| Icosabutate | ⤷ Try a Trial | Methods of treatment using lipid compounds | PRONOVA BIOPHARMA NORGE AS (Lysaker, NO) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Icosabutate
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Icosabutate | Australia | AU2017261372 | 2036-05-05 | ⤷ Try a Trial |
| Icosabutate | Canada | CA3023278 | 2036-05-05 | ⤷ Try a Trial |
| Icosabutate | China | CN107847398 | 2036-05-05 | ⤷ Try a Trial |
| Icosabutate | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Try a Trial |
| Icosabutate | European Patent Office | EP3981392 | 2036-05-05 | ⤷ Try a Trial |
| Icosabutate | Hong Kong | HK1249728 | 2036-05-05 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
